Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH4 | P08319 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | BIRC2 | Q13490 | 3/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.40 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14730979 | 1.00 | ZDHHC7 (0.58) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL20514344 | 1.00 | ZDHHC7 (0.58) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL9860634 | 0.92 | CA1 (0.55) | ZDHHC7CA2CA1ABCB1 | |
| SCHEMBL6155156 | 0.85 | ZDHHC7 (0.44) | ZDHHC7CA2ADH1BADH1CADH1A | |
| SCHEMBL6154829 | 0.85 | ZDHHC7 (0.44) | ZDHHC7CA2ADH1BADH1CADH1A | |
| SCHEMBL3184670 | 0.85 | ZDHHC7 (0.44) | ZDHHC7CA2ADH1BADH1CADH1A | |
| SCHEMBL5560870 | 0.84 | CA1 (0.44) | ZDHHC7CA2CA1ABCB1 | |
| SCHEMBL4963285 | 0.84 | ZDHHC7 (0.56) | ZDHHC7CA2CA1ABCB1USP2 | |
| SCHEMBL29825065 | 0.84 | NAAA (0.48) | ZDHHC7LMNAEPHX1MAPTFAAH | |
| SCHEMBL8069085 | 0.84 | ZDHHC7 (0.56) | ZDHHC7CA2CA1ABCB1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3112373-B1 | NOVEL TETRADENTATE PHOSPHORUS LIGAND WITH HOSTANOX O3 GUIDE STRUCTURE | EVONIK DEGUSSA GMBH (DE) | 2017-08-30 | — | — | EP | disclosed |
| EP-3112373-A1 | NOVEL TETRADENTATE PHOSPHORUS LIGAND WITH HOSTANOX O3 GUIDE STRUCTURE | Evonik Degussa GmbH (DE) | 2017-01-04 | — | — | EP | disclosed |
| EP-2991996-B1 | NEW QUADRIDENTATE PHOSPHORUS LIGANDS COMPRISING HOSTANOX O3 CONDUCTIVE STRUCTURE | EVONIK DEGUSSA GMBH (DE) | 2016-08-24 | — | — | EP | disclosed |
| US-20160159841-A1 | LOW-ISOMERIZATION HYDROFORMYLATION OF OLEIC-ACID-ESTER-CONTAINING MIXTURES | EVONIK DEGUSSA GMBH (DE) | 2016-06-09 | — | — | US | disclosed |
| EP-2991996-A1 | NEW QUADRIDENTATE PHOSPHORUS LIGANDS COMPRISING HOSTANOX O3 CONDUCTIVE STRUCTURE | Evonik Degussa GmbH (DE) | 2016-03-09 | — | — | EP | disclosed |
| WO-2015011152-A2 | LOW-ISOMERIZATION HYDROFORMYLATION OF OELIC-ACID-ESTER-CONTAINING MIXTURES | EVONIK INDUSTRIES AG (DE) | 2015-01-29 | — | — | WO | disclosed |
| EP-2829546-A2 | Low isomerisation hydroformylation of mixtures containing oleic acid esters | Evonik Industries AG (DE) | 2015-01-28 | — | — | EP | disclosed |
| WO-2014177355-A1 | NEW QUADRIDENTATE PHOSPHORUS LIGANDS COMPRISING HOSTANOX O3 CONDUCTIVE STRUCTURE | EVONIK INDUSTRIES AG (DE) | 2014-11-06 | — | — | WO | disclosed |
| US-20100087350-A1 | CAPPED POLYESTER POLYOL LUBRICANT COMPOSITION | DOW GLOBAL TECHNOLOGIES LLC | 2010-04-08 | — | — | US | disclosed |
| EP-2134822-A2 | CAPPED POLYESTER POLYOL LUBRICANT COMPOSITION | Dow Global Technologies Inc. (US) | 2009-12-23 | — | — | EP | disclosed |
| WO-2008124265-A2 | CAPPED POLYESTER POLYOL LUBRICANT COMPOSITION | DOW GLOBAL TECHNOLOGIES, INC. (US) | 2008-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160159841-A1 | LOW-ISOMERIZATION HYDROFORMYLATION OF OLEIC-ACID-ESTER-CONTAINING MIXTURES | ELOVL3, ELOVL6, ELOVL5 | ZDHHC7 211/4885CA2 2678/4885CA1 1486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.